This week, Google announced plans for smart contact lenses that will help people with diabetes track their blood glucose levels.
Right now, many of the 347 million people who have diabetes worldwide monitor their blood sugar levels by pricking their fingers and testing the blood. Google wants to replace needles and blood with a contact lens and tears.
Read more: http://www.businessinsider.com/google-diabetes-contacts-2014-1#ixzz2qnhXtDmW
A new therapeutic approach to diabetes that combines insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin could limit the progression of diabetic macular edema (DME), Cleveland Clinic researcher Bela Anand-Apte, MD, PhD, said at the American Society for Cell Biology Annual Meeting, in San Francisco.
The study, conducted with insulin-dependent diabetic mice, showed that by thwarting “cross-talk” between insulin and betacellulin (BTC), which promotes the regeneration of pancreatic beta cells that stores and releases insulin, the EGF inhibitor preserved the animals’ vascular integrity, she explained.